These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 38842181)
1. Supramolecular assembly of isomeric SN-38 prodrugs regulated by conjugation sites. Tang Z; Zhang J; Li W; Wen K; Gu Z; Zhou D; Su H J Mater Chem B; 2024 Jun; 12(25):6146-6154. PubMed ID: 38842181 [TBL] [Abstract][Full Text] [Related]
2. Spontaneous assembly of a class of small molecule prodrugs directed by SN38. Tang Z; Lan W; Wen K; Li W; Wang T; Zhou D; Su H J Mater Chem B; 2024 Oct; 12(39):9921-9929. PubMed ID: 39252501 [TBL] [Abstract][Full Text] [Related]
3. Supramolecular prodrug of SN38 based on endogenous albumin and SN38 prodrug modified with semaglutide side chain to improve the tumor distribution. Wei Q; Wu Y; Jiang X; Lu W; Liu S; Yu J Bioorg Med Chem; 2024 May; 106():117754. PubMed ID: 38728869 [TBL] [Abstract][Full Text] [Related]
4. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity. Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251 [TBL] [Abstract][Full Text] [Related]
5. Synergistic action of doxorubicin and 7-Ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug. Wu Z; Li S; Cai Y; Chen F; Chen Y; Luo X Colloids Surf B Biointerfaces; 2020 May; 189():110741. PubMed ID: 32032928 [TBL] [Abstract][Full Text] [Related]
6. Novel SN38 conjugate-forming nanoparticles as anticancer prodrug: in vitro and in vivo studies. Zhang H; Wang J; Mao W; Huang J; Wu X; Shen Y; Sui M J Control Release; 2013 Mar; 166(2):147-58. PubMed ID: 23266448 [TBL] [Abstract][Full Text] [Related]
7. Fine-Tuning the Linear Release Rate of Paclitaxel-Bearing Supramolecular Filament Hydrogels through Molecular Engineering. Chakroun RW; Wang F; Lin R; Wang Y; Su H; Pompa D; Cui H ACS Nano; 2019 Jul; 13(7):7780-7790. PubMed ID: 31117370 [TBL] [Abstract][Full Text] [Related]
8. Monodisperse oligoethylene glycols modified Camptothecin, 10-Hydroxycamptothecin and SN38 prodrugs. Deng T; Mao X; Xiao Y; Yang Z; Zheng X; Jiang ZX Bioorg Med Chem Lett; 2019 Feb; 29(4):581-584. PubMed ID: 30600208 [TBL] [Abstract][Full Text] [Related]
9. "Sweet tooth"-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy. Ding N; Xu S; Zheng S; Ye Q; Xu L; Ling S; Xie S; Chen W; Zhang Z; Xue M; Lin Z; Xu X; Wang L J Mater Chem B; 2021 Mar; 9(12):2816-2830. PubMed ID: 33690741 [TBL] [Abstract][Full Text] [Related]
10. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells. Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; QuiƱones-Hinojosa A; Cui H Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839 [TBL] [Abstract][Full Text] [Related]
11. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects. Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086 [TBL] [Abstract][Full Text] [Related]
12. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. Liu Z; Robinson JT; Sun X; Dai H J Am Chem Soc; 2008 Aug; 130(33):10876-7. PubMed ID: 18661992 [TBL] [Abstract][Full Text] [Related]
13. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon. Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526 [TBL] [Abstract][Full Text] [Related]
14. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy. Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058 [TBL] [Abstract][Full Text] [Related]
16. A supramolecular assembly mediated by host-guest interactions for improved chemo-photodynamic combination therapy. Mao W; Liao Y; Ma D Chem Commun (Camb); 2020 Apr; 56(30):4192-4195. PubMed ID: 32167514 [TBL] [Abstract][Full Text] [Related]
17. Integrating a novel SN38 prodrug into the PEGylated liposomal system as a robust platform for efficient cancer therapy in solid tumors. Fang T; Dong Y; Zhang X; Xie K; Lin L; Wang H Int J Pharm; 2016 Oct; 512(1):39-48. PubMed ID: 27544846 [TBL] [Abstract][Full Text] [Related]
18. Carrier-free nano-prodrugs for minimally invasive cancer therapy. Tanita K; Koseki Y; Kumar S; Taemaitree F; Mizutani A; Nakatsuji H; Suzuki R; Dao ATN; Fujishima F; Tada H; Ishida T; Saijo K; Ishioka C; Kasai H Nanoscale; 2024 Aug; 16(32):15256-15264. PubMed ID: 39073351 [TBL] [Abstract][Full Text] [Related]
19. The role of critical micellization concentration in efficacy and toxicity of supramolecular polymers. Su H; Wang F; Ran W; Zhang W; Dai W; Wang H; Anderson CF; Wang Z; Zheng C; Zhang P; Li Y; Cui H Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4518-4526. PubMed ID: 32071209 [TBL] [Abstract][Full Text] [Related]
20. Injectable Reactive Oxygen Species-Responsive SN38 Prodrug Scaffold with Checkpoint Inhibitors for Combined Chemoimmunotherapy. Gong Y; Chen M; Tan Y; Shen J; Jin Q; Deng W; Sun J; Wang C; Liu Z; Chen Q ACS Appl Mater Interfaces; 2020 Nov; 12(45):50248-50259. PubMed ID: 33135879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]